US Patent Issued to Myriad Genetics on Sept. 23 for "Methods and materials for assessing homologous recombination deficiency" (Utah Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,555, issued on Sept. 23, was assigned to Myriad Genetics Inc. (Salt Lake City).

"Methods and materials for assessing homologous recombination deficiency" was invented by Victor Abkevich (Salt Lake City), Kirsten Timms (Salt Lake City), Alexander Gutin (Salt Lake City) and Julia Reid (Salt Lake City).

According to the abstract* released by the U.S. Patent & Trademark Office: "This document provides methods and materials involved in assessing samples (e.g., cancer cells) for the presence of homologous recombination deficiency (HRD) or an HRD signature. For example, methods and materials for determining whether or not a cell (e.g., a cancer cell) contains an HRD signature are provi...